Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Clin Cancer Res OF1–OF14.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-4774

Published: 27 June 2022

View article

Includes: Supplementary data

Journal Articles

Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer

Jodi M. Carter, Mei-Yin C. Polley, Roberto A. Leon-Ferre, Jason Sinnwell, Kevin J. Thompson, Xue Wang, Yaohua Ma, David Zahrieh, Jennifer M. Kachergus, Malvika Solanki, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, E. Aubrey Thompson, Matthew P. Goetz

Clin Cancer Res (2021) 27 (20): 5628–5637.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-0343

Published: 15 October 2021

View article

Includes: Supplementary data

Journal Articles

Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)

Clin Cancer Res (2021) 27 (17): 4696–4699.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-0641

Published: 01 September 2021

View article

Journal Articles

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clin Cancer Res (2020) 26 (12): 2986–2996.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-3091

Published: 15 June 2020

View article

Includes: Supplementary data

Journal Articles

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2⁺ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Amylou C. Dueck, Monica M. Reinholz, Xochiquetzal J. Geiger, Kathleen Tenner, Karla Ballman, Robert B. Jenkins, Darren Riehle, Beiyun Chen, Ann E. McCullough, Nancy E. Davidson, Silvana Martino, George W. Sledge, Peter A. Kaufman, Leila A. Kutteh, Julie Gralow, Lyndsay N. Harris, James N. Ingle, Wilma L. Lingle, Edith A. Perez

Clin Cancer Res (2013) 19 (20): 5798–5807.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-0558

Published: 14 October 2013

View article

Includes: Supplementary data

Journal Articles

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Clin Cancer Res (2013) 19 (19): 5505–5512.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-3327

Published: 01 October 2013

View article

Includes: Supplementary data

Journal Articles

Mammographic Breast Density Response to Aromatase Inhibition

Celine M. Vachon, Vera J. Suman, Kathleen R. Brandt, Matthew L. Kosel, Aman U. Buzdar, Janet E. Olson, Fang-Fang Wu, Lynn M. Flickinger, Giske Ursin, Catherine R. Elliott, Lois Shepherd, Richard M. Weinshilboum, Paul E. Goss, James N. Ingle

Clin Cancer Res (2013) 19 (8): 2144–2153.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-2789

Published: 15 April 2013

View article

Journal Articles

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Matthew P. Goetz, Vera J. Suman, Tanya L. Hoskin, Michael Gnant, Martin Filipits, Stephanie L. Safgren, Mary Kuffel, Raimund Jakesz, Margaretha Rudas, Richard Greil, Otto Dietze, Alois Lang, Felix Offner, Carol A. Reynolds, Richard M. Weinshilboum, Matthew M. Ames, James N. Ingle

Clin Cancer Res (2013) 19 (2): 500–507.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-2153

Published: 16 January 2013

View article

Journal Articles

Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials

Matthew P. Goetz, Daniel J. Schaid, D. Lawrence Wickerham, Stephanie Safgren, Taisei Mushiroda, Michiaki Kubo, Anthony Batzler, Joseph P. Costantino, Victor G. Vogel, Soonmyung Paik, Erin E. Carlson, David A. Flockhart, Norman Wolmark, Yusuke Nakamura, Richard M. Weinshilboum, James N. Ingle, Matthew M. Ames

Clin Cancer Res (2011) 17 (21): 6944–6951.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0860

Published: 31 October 2011

View article

Includes: Supplementary data

Journal Articles

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

Jonathan F. Lara, Ann D. Thor, Lynn G. Dressler, Gloria Broadwater, Ira J. Bleiweiss, Susan Edgerton, David Cowan, Lori J. Goldstein, Silvana Martino, James N. Ingle, I. Craig Henderson, Larry Norton, Eric P. Winer, Clifford A. Hudis, Matthew J. Ellis, Donald A. Berry, Daniel F. Hayes, for the Cancer and Leukemia Group B

Clin Cancer Res (2011) 17 (15): 5170–5178.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0484

Published: 31 July 2011

View article

Journal Articles

A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu_88-102

Lavakumar Karyampudi, Courtney Formicola, Courtney L. Erskine, Matthew J. Maurer, James N. Ingle, Christopher J. Krco, Peter J. Wettstein, Kimberly R. Kalli, John D. Fikes, Melanie Beebe, Lynn C. Hartmann, Mary L. Disis, Soldano Ferrone, Glenn Ishioka, Keith L. Knutson

Clin Cancer Res (2010) 16 (3): 825–834.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-2781

Published: 01 February 2010

View article

Journal Articles

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

Steven E. Come, Aman U. Buzdar, James N. Ingle, Carlos L. Arteaga, Angela M. Brodie, Graham A. Colditz, Stephen R.D. Johnston, Vessela N. Kristensen, Per E. Lønning, Donald P. McDonnell, C. Kent Osborne, Jose Russo, Richard J. Santen, Douglas Yee, Carol S. Hart

Clin Cancer Res (2005) 11 (2): 861s–864s.

DOI: https://doi.org/10.1158/1078-0432.861s.11.2

Published: 01 September 2009

View article

Journal Articles

Endocrine Therapy Trials of Aromatase Inhibitors for Breast Cancer in the Adjuvant and Prevention Settings

James N. Ingle

Clin Cancer Res (2005) 11 (2): 900s–905s.

DOI: https://doi.org/10.1158/1078-0432.900s.11.2

Published: 01 September 2009

View article

Journal Articles

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

Steven E. Come, Aman U. Buzdar, Carlos L. Arteaga, Mina J. Bissell, Myles A. Brown, Matthew J. Ellis, Paul E. Goss, Jeffrey E. Green, James N. Ingle, Adrian V. Lee, Daniel Medina, Robert I. Nicholson, Richard J. Santen, Rachel Schiff, Carol S. Hart

Clin Cancer Res (2004) 10 (1): 327s–330s.

DOI: https://doi.org/10.1158/1078-0432.CCR-031213

Published: 01 September 2009

View article

Journal Articles

Sequencing of Endocrine Therapy in Postmenopausal Women with Advanced Breast Cancer

James N. Ingle

Clin Cancer Res (2004) 10 (1): 362s–367s.

DOI: https://doi.org/10.1158/1078-0432.CCR-031200

Published: 01 September 2009

View article

Journal Articles

Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen Resistance

Matthew P. Goetz, Vera J. Suman, Fergus J. Couch, Matthew M. Ames, James M. Rae, Mark G. Erlander, Xiao-Jun Ma, Dennis C. Sgroi, Carol A. Reynolds, Wilma L. Lingle, Richard M. Weinshilboum, David A. Flockhart, Zeruesenay Desta, Edith A. Perez, James N. Ingle

Clin Cancer Res (2008) 14 (18): 5864–5868.

DOI: https://doi.org/10.1158/1078-0432.CCR-08-0619

Published: 14 September 2008

View article

Journal Articles

A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen

Matthew P. Goetz, Vera J. Suman, James N. Ingle, Andrea M. Nibbe, Dan W. Visscher, Carol A. Reynolds, Wilma L. Lingle, Mark Erlander, Xiao-Jun Ma, Dennis C. Sgroi, Edith A. Perez, Fergus J. Couch

Clin Cancer Res (2006) 12 (7): 2080–2087.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-1263

Published: 11 April 2006

View article

Journal Articles

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement

Steven E. Come, Aman U. Buzdar, James N. Ingle, Carlos L. Arteaga, Myles Brown, Mitch Dowsett, Susan G. Hilsenbeck, Rakesh Kumar, Stephen R.D. Johnston, Adrian V. Lee, Soonmyung Paik, Kathleen I. Pritchard, Eric P. Winer, Carol Hart

Clin Cancer Res (2006) 12 (3): 997s–1000s.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-2268

Published: 07 February 2006

View article

Journal Articles

Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer

James N. Ingle

Clin Cancer Res (2006) 12 (3): 1031s–1036s.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-2122

Published: 07 February 2006

View article

Journal Articles

Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

Monica M. Reinholz, Andrea Nibbe, Leslie M. Jonart, Kathleen Kitzmann, Vera J. Suman, James N. Ingle, Raymond Houghton, Barbara Zehentner, Patrick C. Roche, Wilma L. Lingle

Clin Cancer Res (2005) 11 (10): 3722–3732.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-1483

Published: 16 May 2005

View article

NARROW

Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer

Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2⁺ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Mammographic Breast Density Response to Aromatase Inhibition

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu_88-102

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

Endocrine Therapy Trials of Aromatase Inhibitors for Breast Cancer in the Adjuvant and Prevention Settings

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

Sequencing of Endocrine Therapy in Postmenopausal Women with Advanced Breast Cancer

Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen Resistance

A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement

Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer

Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only